What is the share price of Poly Medicure Ltd (POLYMED) today?
The share price of POLYMED as on 5th December 2025 is ₹1889.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Poly Medicure Ltd (POLYMED) share?
The past returns of Poly Medicure Ltd (POLYMED) share are- Past 1 week: 0.56%
- Past 1 month: -0.45%
- Past 3 months: -6.02%
- Past 6 months: -14.59%
- Past 1 year: -33.55%
- Past 3 years: 98.22%
- Past 5 years: 286.02%
What are the peers or stocks similar to Poly Medicure Ltd (POLYMED)?
The peers or stocks similar to Poly Medicure Ltd (POLYMED) include:What is the dividend yield % of Poly Medicure Ltd (POLYMED) share?
The current dividend yield of Poly Medicure Ltd (POLYMED) is 0.18.What is the market cap of Poly Medicure Ltd (POLYMED) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Poly Medicure Ltd (POLYMED) is ₹19367.77 Cr as of 5th December 2025.What is the 52 week high and low of Poly Medicure Ltd (POLYMED) share?
The 52-week high of Poly Medicure Ltd (POLYMED) is ₹3031 and the 52-week low is ₹1821.20.What is the PE and PB ratio of Poly Medicure Ltd (POLYMED) stock?
The P/E (price-to-earnings) ratio of Poly Medicure Ltd (POLYMED) is 57.21. The P/B (price-to-book) ratio is 7.00.Which sector does Poly Medicure Ltd (POLYMED) belong to?
Poly Medicure Ltd (POLYMED) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Poly Medicure Ltd (POLYMED) shares?
You can directly buy Poly Medicure Ltd (POLYMED) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Poly Medicure Ltd
POLYMED Share Price
1,889.801.10% (-21.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
POLYMED Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
POLYMED Performance & Key Metrics
POLYMED Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 53.51 | 7.00 | 0.18% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
67%
Analysts have suggested that investors can buy this stock
from 6 analysts
Price Upside
Earnings Growth
Rev. Growth
POLYMED Company Profile
Poly Medicure Limited is engaged in the manufacturing and sale of medical devices.
PE Ratio
57.38
57.38
1Y Return
15.01%
15.01%
Buy Reco %
71.43
71.43
FISCHER
PE Ratio
2,040.43
2,040.43
1Y Return
39.58%
39.58%
Buy Reco %
0.00
0.00
LAXMIDENTL
PE Ratio
47.65
47.65
1Y Return
49.96%
49.96%
Buy Reco %
100.00
100.00
TARSONS
PE Ratio
40.73
40.73
1Y Return
48.19%
48.19%
Buy Reco %
100.00
100.00
BOROSCI
PE Ratio
40.94
40.94
1Y Return
31.97%
31.97%
Buy Reco %
0.00
0.00
POLYMED Sentiment Analysis
POLYMED Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
POLYMED Stock Summary · November 2025
Poly Medicure Limited is strategically enhancing its market presence through significant acquisitions and a robust product development pipeline, aiming to launch 20 new products in Cardiology and Critical Care. With a strong liquidity position of Rs. 1,109 crores, the company is poised for growth despite facing challenges in capturing a larger market share, currently at 2%-3% of the global medical technology market. Domestic revenue has shown resilience, particularly in the renal segment, which is projected to drive future growth. However, international operations are grappling with regulatory hurdles and competitive pressures, necessitating careful integration of recent acquisitions to maintain EBITDA margins. Overall, the company remains optimistic about achieving its revenue targets, supported by ongoing investments in capacity expansion and operational improvements.
POLYMED Stock Growth Drivers
POLYMED Stock Growth Drivers
8Strategic Acquisitions
Poly Medicure Limited has successfully completed the acquisition of Italy-based Citieffe Group, enhancing its presence
Financial Performance
For the half-year ended September 2025, Poly Medicure reported consolidated revenue of Rs. 847 crores,
POLYMED Stock Challenges
POLYMED Stock Challenges
3Decline in Government Business
The company has experienced a significant decline in its government business, which has decreased by
Challenges in the U.S. Market
The company faces ongoing challenges in the U.S. market, primarily due to a 50% tariff
POLYMED Forecast
POLYMED Forecasts
Price
Revenue
Earnings
POLYMED Share Price Forecast
POLYMED Share Price Forecast
2025
Current
₹1,910.80
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹1,910.80
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
POLYMED Company Revenue Forecast
POLYMED Company Revenue Forecast
2025
Current
₹1.76
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.76
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
POLYMED Stock EPS (Earnings Per Share) Forecast
POLYMED Stock EPS (Earnings Per Share) Forecast
2025
Current
₹34.32
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹34.32
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
POLYMED
POLYMED
Income
Balance Sheet
Cash Flow
Annual Normal View
POLYMED Income Statement
POLYMED Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 468.95 | 536.04 | 630.50 | 707.84 | 808.20 | 963.41 | 1,153.34 | 1,437.07 | 1,764.14 | 1,840.58 | ||||||||||
Raw Materials | 119.62 | 176.07 | 165.66 | 178.89 | 214.22 | 296.55 | 345.37 | 382.51 | 471.68 | 1,257.74 | ||||||||||
| Power & Fuel Cost | 16.78 | 19.04 | 24.74 | 25.62 | 25.27 | 29.84 | 38.59 | 44.29 | 53.56 | |||||||||||
| Employee Cost | 87.26 | 99.13 | 116.61 | 138.76 | 141.76 | 163.62 | 202.75 | 245.91 | 301.53 | |||||||||||
| Selling & Administrative Expenses | 47.08 | 45.24 | 58.05 | 61.03 | 56.20 | 66.97 | 77.78 | 96.11 | 126.12 | |||||||||||
| Operating & Other expenses | 90.80 | 58.98 | 114.53 | 116.82 | 132.53 | 151.07 | 183.34 | 246.98 | 261.78 | |||||||||||
EBITDA | 107.41 | 137.58 | 150.91 | 186.72 | 238.22 | 255.36 | 305.51 | 421.27 | 549.47 | 582.84 | ||||||||||
| Depreciation/Amortization | 23.73 | 29.24 | 37.29 | 40.53 | 47.52 | 53.95 | 57.17 | 63.44 | 82.64 | 90.73 | ||||||||||
| PBIT | 83.68 | 108.34 | 113.62 | 146.19 | 190.70 | 201.41 | 248.34 | 357.83 | 466.83 | 492.11 | ||||||||||
| Interest & Other Items | 8.49 | 11.58 | 13.53 | 20.48 | 10.64 | 6.16 | 10.86 | 13.56 | 14.32 | 11.42 | ||||||||||
| PBT | 75.19 | 96.76 | 100.09 | 125.71 | 180.06 | 195.25 | 237.48 | 344.27 | 452.51 | 480.69 | ||||||||||
| Taxes & Other Items | 20.06 | 26.16 | 34.67 | 29.85 | 44.18 | 48.74 | 58.21 | 86.01 | 113.95 | 118.75 | ||||||||||
| Net Income | 55.13 | 70.60 | 65.42 | 95.86 | 135.88 | 146.51 | 179.27 | 258.26 | 338.56 | 361.94 | ||||||||||
| EPS | 6.25 | 8.00 | 7.41 | 10.86 | 14.76 | 15.28 | 18.69 | 26.91 | 34.32 | 35.72 | ||||||||||
| DPS | 2.50 | 2.00 | 2.00 | 2.00 | 2.50 | 2.50 | 3.00 | 3.00 | 3.50 | 3.50 | ||||||||||
| Payout ratio | 0.40 | 0.25 | 0.27 | 0.18 | 0.17 | 0.16 | 0.16 | 0.11 | 0.10 | 0.10 |
POLYMED Company Updates
FY 2026FY 2026
Investor Presentation
Nov 8PDF
Sep 3PDF
POLYMED Stock Peers
POLYMED Past Performance & Peer Comparison
POLYMED Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Poly Medicure Ltd | 57.21 | 7.00 | 0.18% |
| Inventurus Knowledge Solutions Ltd | 57.38 | 15.58 | — |
| Fischer Medical Ventures Ltd | 2,040.43 | 9.00 | 0.10% |
| Laxmi Dental Ltd | 47.65 | 7.26 | — |
POLYMED Stock Price Comparison
Compare POLYMED with any stock or ETFCompare POLYMED with any stock or ETF
POLYMED
POLYMED Holdings
POLYMED Shareholdings
POLYMED Promoter Holdings Trend
POLYMED Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
POLYMED Institutional Holdings Trend
POLYMED Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 1.63%
POLYMED Shareholding Pattern
POLYMED Shareholding Pattern
POLYMED Shareholding History
POLYMED Shareholding History
Foreign Institutions
Mutual Funds Invested in POLYMED
Mutual Funds Invested in POLYMED
No mutual funds holding trends are available
Top 5 Mutual Funds holding Poly Medicure Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.3967% | Percentage of the fund’s portfolio invested in the stock 2.16% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/118 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.3886% | Percentage of the fund’s portfolio invested in the stock 1.05% | Change in the portfolio weight of the stock over the last 3 months -0.09% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 30/62 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6175% | Percentage of the fund’s portfolio invested in the stock 2.94% | Change in the portfolio weight of the stock over the last 3 months 0.24% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 17/34 (+3) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing POLYMED stock
smallcases containing POLYMED stock
Looks like this stock is not in any smallcase yet.
POLYMED Events
POLYMED Events
POLYMED Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
POLYMED has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.18%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.83 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
POLYMED Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
POLYMED has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.18%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.83 every year
POLYMED Upcoming Dividends
POLYMED Upcoming Dividends
No upcoming dividends are available
POLYMED Past Dividends
POLYMED Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2025
Final
Final | Div/Share: ₹3.50
Dividend/Share
₹3.50
Ex DateEx Date
Sep 18, 2025
Cash Dividend
Ex DateEx DateSep 19, 2024
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 19, 2024
Cash Dividend
Ex DateEx DateSep 21, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 21, 2023
Cash Dividend
Ex DateEx DateSep 16, 2022
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 16, 2022
Cash Dividend
Ex DateEx DateSep 16, 2021
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 16, 2021
POLYMED Stock News & Opinions
POLYMED Stock News & Opinions
Articles & Videos
Spotlight
Volumes soar at Poly Medicure Ltd counter
Syrma SGS Technology Ltd, Transformers & Rectifiers India Ltd, HEG Ltd, K E C International Ltd are among the other stocks to see a surge in volumes on NSE today, 11 November 2025.Poly Medicure Ltd clocked volume of 23.67 lakh shares by 14:14 IST on NSE, a 22.16 times surge over two-week average daily volume of 1.07 lakh shares. The stock gained 11.15% to Rs.2,070.00. Volumes stood at 1.18 lakh shares in the last session.Syrma SGS Technology Ltd clocked volume of 178.41 lakh shares by 14:14 IST on NSE, a 14.45 times surge over two-week average daily volume of 12.35 lakh shares. The stock gained 3.34% to Rs.835.00. Volumes stood at 12.05 lakh shares in the last session.Transformers & Rectifiers India Ltd saw volume of 235.21 lakh shares by 14:14 IST on NSE, a 13.5 fold spurt over two-week average daily volume of 17.42 lakh shares. The stock dropped 9.63% to Rs.283.35. Volumes stood at 32.29 lakh shares in the last session.HEG Ltd witnessed volume of 227.08 lakh shares by 14:14 IST on NSE, a 9.84 times surge over two-week average daily volume of 23.07 lakh shares. The stock increased 3.89% to Rs.539.50. Volumes stood at 15.31 lakh shares in the last session.K E C International Ltd registered volume of 53.21 lakh shares by 14:14 IST on NSE, a 9.64 fold spurt over two-week average daily volume of 5.52 lakh shares. The stock rose 5.32% to Rs.760.65. Volumes stood at 12.77 lakh shares in the last session.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Poly Medicure consolidated net profit rises 5.02% in the September 2025 quarter
Net profit of Poly Medicure rose 5.02% to Rs 91.84 crore in the quarter ended September 2025 as against Rs 87.45 crore during the previous quarter ended September 2024. Sales rose 5.68% to Rs 443.88 crore in the quarter ended September 2025 as against Rs 420.02 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales443.88420.02 6 OPM %25.8427.42 - PBDT146.62138.70 6 PBT121.69117.98 3 NP91.8487.45 5 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Poly Medicure standalone net profit rises 2.10% in the September 2025 quarter
Net profit of Poly Medicure rose 2.10% to Rs 89.05 crore in the quarter ended September 2025 as against Rs 87.22 crore during the previous quarter ended September 2024. Sales rose 3.50% to Rs 416.54 crore in the quarter ended September 2025 as against Rs 402.47 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales416.54402.47 3 OPM %26.7028.02 - PBDT142.16136.90 4 PBT118.01116.93 1 NP89.0587.22 2 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Poly Medicure announces board meeting date
Poly Medicure will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Poly Medicure to conduct AGM
Poly Medicure announced that the Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Poly Medicure consolidated net profit rises 25.72% in the June 2025 quarter
Net profit of Poly Medicure rose 25.72% to Rs 93.08 crore in the quarter ended June 2025 as against Rs 74.04 crore during the previous quarter ended June 2024. Sales rose 4.79% to Rs 403.21 crore in the quarter ended June 2025 as against Rs 384.78 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales403.21384.78 5 OPM %26.3227.01 - PBDT146.20118.11 24 PBT122.9598.46 25 NP93.0874.04 26 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Board of Poly Medicure appoints Executive Director
The Board of Poly Medicure at its meeting held on 08 August 2025 has approved appointment of Pankaj Kumar Gupta (DIN: '11232604) as an Executive Director of the Company for a period of Five (5) consecutive years commencing from 08 August 2025. Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Poly Medicure schedules board meeting
Poly Medicure will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Board of Poly Medicure recommends final dividend
Poly Medicure announced that the Board of Directors of the Company at its meeting held on 6 May 2025, inter alia, have recommended the final dividend of Rs 3.5 per equity Share (i.e. 70%) , subject to the approval of the shareholders.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Poly Medicure consolidated net profit rises 34.33% in the March 2025 quarter
Net profit of Poly Medicure rose 34.33% to Rs 91.83 crore in the quarter ended March 2025 as against Rs 68.36 crore during the previous quarter ended March 2024. Sales rose 16.60% to Rs 440.83 crore in the quarter ended March 2025 as against Rs 378.07 crore during the previous quarter ended March 2024. For the full year,net profit rose 31.09% to Rs 338.56 crore in the year ended March 2025 as against Rs 258.26 crore during the previous year ended March 2024. Sales rose 21.37% to Rs 1669.83 crore in the year ended March 2025 as against Rs 1375.80 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales440.83378.07 17 1669.831375.80 21 OPM %27.1025.51 -27.1226.00 - PBDT143.88108.54 33 535.15407.71 31 PBT122.8592.46 33 452.52344.27 31 NP91.8368.36 34 338.56258.26 31 Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 20.04%, vs industry avg of 24.67%
Over the last 5 years, market share decreased from 33.85% to 23.63%
Over the last 5 years, net income has grown at a yearly rate of 28.71%, vs industry avg of 28.7%